Recreational Anabolic-Androgenic Steroid Use Associated With Liver Injuries Among Brazilian Young Men

REFERENCES

• Abrahin, O. S. C., Sousa, E. C., & Santos, A. M. (2014). Prevalence of the use of anabolic-androgenic steroids in Brazil: A systematic review. Substance Use & Misuse, 49(9), 1156–1162.
   PubMed Web of Science ®Google Scholar
• Abramson, J. H. (2011). WINPEPI updated: Computer programs for epidemiologists, and their teaching potential. Epidemiologic Perspectives & Innovations, 8(1), 1.
   PubMedGoogle Scholar
• Aitken, C., Delalande, C., & Stanton, K. (2002). Pumping iron, risking infection? Exposure to hepatitis C, hepatitis B and HIV among anabolic-androgenic steroid injectors in Victoria, Australia. Drug and Alcohol Dependence, 65(3), 303–308.
   PubMed Web of Science ®Google Scholar
• Bahrke, M. S., & Yesalis, C. E. (2004). Abuse of anabolic androgenic steroids and related substances in sport and exercise. Current Opinion in Pharmacology, 4(6), 614–620.
   PubMed Web of Science ®Google Scholar
• Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., & Casaburi, R. (1996). The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. The New England Journal of Medicine, 335(1), 1–7.
   PubMed Web of Science ®Google Scholar
• Bispo, M., Valente, A., Maldonado, R., Palma, R., Glória, H., Nóbrega, J., & Alexandrino, P. (2009). Anabolic steroid-induced cardiomyopathy underlying acute liver failure in a young bodybuilder. World Journal of Gastroenterology, 15(23), 2920–2922.
   PubMed Web of Science ®Google Scholar
• Crampin, A. C., Lamagni, T. L., Hope, V. D., Newham, J. A., Lewis, K. M., Parry, J. V., & Gill, O. N. (1998). The risk of infection with HIV and hepatitis B in individuals who inject steroids in England and Wales. Epidemiology & Infection, 121(2), 381–386.
   PubMed Web of Science ®Google Scholar
• Evans, N. A. (2004) Current concepts in anabolic-androgenic steroids. American Journal of Sports Medicine, 32(2), 534–542.
   PubMed Web of Science ®Google Scholar
• Gomez, J. (2005). Use of performance-enhancing substances. Pediatrics, 115(4), 1103–1106.
   PubMed Web of Science ®Google Scholar
• Gorayski, P., Thompson, C. H., Subhash, H. S., & Thomas, A. C. (2008). Hepatocellular carcinoma associated with recreational anabolic steroid use. British Journal of Sports Medicine, 42(1), 74–75.
   PubMed Web of Science ®Google Scholar
• Gragera, R., Saborido, A., Molano, F., Jimenez, L., Muniz, E., & Megias, A. (1993). Ultrastructural changes induced by anabolic steroids in liver of trained rats. Histology and Histopathology, 8(3), 449–455.
   PubMed Web of Science ®Google Scholar
• Griggs, R. C., Kingston, W., Jozefowicz, R. F., Herr, B. E., Forbes, G., & Halliday, D. (1989). Effect of testosterone on muscle mass and muscle protein synthesis. Journal of Applied Physiology, 66(1), 498–503.
   PubMed Web of Science ®Google Scholar
• Guidorizzi de Siqueira, A. C., Cotrim, H. P., Rocha, R., Carvalho, F. M., de Freitas, L. A., Barreto, D., & Landeiro, L. (2005). Non-alcoholic fatty liver disease and insulin resistance: Importance of risk factors and histological spectrum. European Journal of Gastroenterology & Hepatology, 17(8), 837–841.
   PubMed Web of Science ®Google Scholar
• Hakansson, A., Mickelsson, K., Wallin, C., & Berglund, M. (2012). Anabolic androgenic steroids in the general population: User characteristics and associations with substance use. European Addiction Research, 18(2), 83–90.
   PubMed Web of Science ®Google Scholar
• Kafrouni, M. I., Anders, R. A., & Verma, S. (2007). Hepatotoxicity associated with dietary supplements containing anabolic steroids. Clinical Gastroenterology and Hepatology, 5(7), 809–812.
   PubMed Web of Science ®Google Scholar
• Kanayama, G., Boynes, M., Hudson, J. I., Field, A. E., & Pope, H. G. Jr. (2007). Anabolic steroid abuse among teenage girls: An illusory problem? Drug and Alcohol Dependence, 88(2–3), 156–162.
   PubMed Web of Science ®Google Scholar
• Kretzer, I. F., do Livramento, A., da Cunha, J., Gonçalves, S., Tosin, I., Spada, C., & Treitinger, A. (2014). Hepatitis C worldwide and in Brazil: Silent epidemic—data on disease including incidence, transmission, prevention, and treatment. The Scientific World Journal, 2014, 827849.
   Google Scholar
• Kuhl, H., & Wiegratz, I. (2007). Can 19-nortestosterone derivatives be aromatized in the liver of adult humans? Are there clinical implications? Climacteric, 10(4), 344–353.
   PubMed Web of Science ®Google Scholar
• Luciani, A., Kobeiter, H., Maison, P., Cherqui, D., Zafrani, E. S., Dhumeaux, D., & Mathieu, D. (2002). Focal nodular hyperplasia of the liver in men: Is presentation the same in men and women? Gut, 50(6), 877–880.
   PubMed Web of Science ®Google Scholar
• Mathieu, D., Kobeiter, H., Cherqui, D., Rahmouni, A., & Dhumeaux, D. (1998). Oral contraceptive intake in women with focal nodular hyperplasia of the liver. The Lancet, 352(9141), 1679–1680.
   PubMed Web of Science ®Google Scholar
• Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985). Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412–419.
   PubMed Web of Science ®Google Scholar
• McCullough, M. C., Namias, N., Schulman, C., Gomez, E., Manning, R., Goldberg, S., & Ward, G. C. (2007). Incidence of hepatic dysfunction is equivalent in burn patients receiving oxandrolone and controls. Journal of Burn Care & Research, 28(3), 412–420.
   PubMed Web of Science ®Google Scholar
• Neri, M., Bello, S., Bonsignore, A., Cantatore, S., Riezzo, I., Turillazzi, E., & Fineschi V. (2011). Anabolic androgenic steroids abuse and liver toxicity. Mini Reviews in Medicinal Chemistry, 11(5), 430–437.
   PubMed Web of Science ®Google Scholar
• Nogueira, F. R. S., Brito, A. F., de Oliveira, C. V. C., Vieira, T. I., & Gouveia R. L. B. (2014). Anabolic–androgenic steroid use among Brazilian bodybuilders. Substance Use & Misuse, 49(9), 1138–1145.
   PubMed Web of Science ®Google Scholar
• Nottin, S., Nguyen, L. D., Terbah, M., & Obert, P. (2006). Cardiovascular effects of androgenic anabolic steroids in male bodybuilders determined by tissue Doppler imaging. American Journal of Cardiology, 97(6), 912–915.
   PubMed Web of Science ®Google Scholar
• O'Shea, R. S., Dasarathy, S., McCullough, A. J. and Practice Guideline Committee of the American Association for the Study of Liver Diseases and the Practice Parameters Committee of the American College of Gastroenterology. (2010). Alcoholic liver disease. Hepatology, 51(1), 307–328.
   PubMed Web of Science ®Google Scholar
• Pagonis, T. A., Koukoulis, G. N., Hadjichristodoulou, C. S., Toli, P. N., & Angelopoulos, N. V. (2008). Multivitamins and phospholipids complex protects the hepatic cells from androgenic-anabolic-steroids-induced toxicity. Clinical Toxicology, 46(1), 57–66.
   Web of Science ®Google Scholar
• Pallesen, S., Josendal, O., Johnsen, B. H., Larsen, S., & Molde H. (2006). Anabolic steroid use in high school students. Substance Use & Misuse, 41(13), 1705–1717.
   PubMed Web of Science ®Google Scholar
• Patil, J. J., O'Donohoe, B., Loyden, C. F., & Shanahan, D. (2007). Near-fatal spontaneous hepatic rupture associated with anabolic androgenic steroid use: A case report. British Journal of Sports Medicine, 41(7), 462–463.
   PubMed Web of Science ®Google Scholar
• Pereira, H. M. G., & Sardela, V. F. (2014). Stimulant doping agents used in Brazil: Prevalence, detectability, analytical implications, and challenges. Substance Use & Misuse, 49(9), 1098–1114.
   PubMed Web of Science ®Google Scholar
• Pereira, L. M., Martelli, C. M., Merchan-Hamann, E., Montarroyos, U. R., Braga, M. C., de Lima, M. L., & Hepatitis Study Group. (2009). Population-based multicentric survey of hepatitis B infection and risk factor differences among three regions in Brazil. The American Journal of Tropical Medicine and Hygiene, 81(2), 240–247.
   PubMed Web of Science ®Google Scholar
• Rosales, X. Q., Chu, M. L., Shilling, C., Wall, C., Pastores, G. M., & Mendell, J. R. (2008). Fidelity of gamma-glutamyl transferase (GGT) in differentiating skeletal muscle from liver damage. Journal of Child Neurology, 23(7), 748–751.
   PubMed Web of Science ®Google Scholar
• Sagoe, D., Molde, H., Andreassen, C. S., Torsheim, T., & Pallesen, S. (2014). The global epidemiology of anabolic-androgenic steroid use: A meta-analysis and meta-regression analysis. Annals of Epidemiology, 24(5), 383–398.
   PubMed Web of Science ®Google Scholar
• Sanchez-Osorio, M., Duarte-Rojo, A., Martinez-Benitez, B., Torre, A., & Uribe, M. (2008). Anabolic-androgenic steroids and liver injury. Liver International, 28(2), 278–282.
   PubMed Web of Science ®Google Scholar
• Santos, A. M., da Rocha, M. S., & da Silva, M. F. (2011). Illicit use and abuse of anabolic-androgenic steroids among Brazilian bodybuilders. Substance Use & Misuse, 46(6), 742–748.
   PubMed Web of Science ®Google Scholar
• Schwingel, P. A., Cotrim, H. P., Salles, B. R., Almeida, C. E., dos Santos, C. R. Jr, Nachef, B., & Zoppi, C. C. (2011). Anabolic-androgenic steroids: A possible new risk factor of toxicant-associated fatty liver disease. Liver International, 31(3), 348–353.
   PubMed Web of Science ®Google Scholar
• Silva, P. R., Machado, L. C. Jr, Figueiredo, V. C., Cioffi, A. P., Prestes, M. C., & Czepielewski MA. (2007). [Prevalence of the use of anabolic agents among strength training apprentices in Porto Alegre, RS]. Arquivos Brasileiros de Endocrinologia & Metabologia, 51(1), 104–110. (In Portugese).
   PubMed Web of Science ®Google Scholar
• Socas, L., Zumbado, M., Perez-Luzardo, O., Ramos, A., Pérez, C., Hernández, J. R., & Boada, L. D. (2005). Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: A report of two cases and a review of the literature. British Journal of Sports Medicine, 39(5), e27.
   PubMed Web of Science ®Google Scholar
• Stimac, D., Milic, S., Dintinjana, R. D., Kovac, D., & Ristic, S. (2002). Androgenic/Anabolic steroid-induced toxic hepatitis. Journal of Clinical Gastroenterology, 35(4), 350–352.
   PubMed Web of Science ®Google Scholar
• Velazquez, I., & Alter, B. P. (2004). Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions. American Journal of Hematology, 77(3), 257–267.
   PubMed Web of Science ®Google Scholar
• Yesalis, C. E., Kennedy, N. J., Kopstein, A. N., & Bahrke, M. S. (1993). Anabolic-androgenic steroid use in the United States. Journal of the American Medical Association, 270(10), 1217–1221.
   PubMed Web of Science ®Google Scholar